Information on new approvals and medication safety that rheumatologists need to know
Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer and editor. She is also a pharmacist at New York Presbyterian Hospital–Lower Manhattan campus. She has been a past guest lecturer at Touro College of Pharmacy in New York City for the Medical Writing elective. Dr Kaufman is a member of the New York City Society of Health-Systems Pharmacy, the New York State Council of Health-System Pharmacists, the Academy of Managed Care Pharmacy (AMCP)—Northeast Region Affiliate Chapter, the American Society of Consultant Pharmacists and the Empire State-Metropolitan NY Chapter of the American Medical Writers Association. She received her BS in Pharmacy from the University of Rhode Island (URI) College of Pharmacy and her Doctor of Pharmacy degree from Massachusetts College of Pharmacy and Allied Health Sciences in Boston. She also completed a Drug Information Fellowship at the URI Drug Information Center/Roger Williams Medical Center in Providence, R.I. Dr Kaufman is a registered pharmacist and is a Board-Certified Geriatric Pharmacist.
Articles by Michele B. Kaufman, PharmD, BCGP
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheumatology Drug Updates
Information on new approvals and medication safety rheumatologists need to know
Rheumatology Drug Updates: Apremilast, Golimumab, and More
Information on new approvals and medication safety rheumatologists need to know
Drug Updates: Lorcaserin, Acetaminophen, and More
information on new approvals and medication safety
Drug Updates: EULAR 2012
Tracking the results of drug safety and efficacy
Drug Updates
Information on new approvals and medication safety.
Drug Updates: Citalopram hydrobromide, Statins, and More
Information on new approvals and medication safety
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety